Literature DB >> 27087022

The Impact of Alternative Payment Models on Oncology Innovation and Patient Care.

Amy M Miller1, Gilbert S Omenn2, Marcia A Kean3.   

Abstract

Oncology care is in a time of major transformation. Scientific discovery is driving breakthroughs in prevention, diagnostics, and treatment, resulting in tremendous gains for patients as the number of cancer survivors continues to grow on an annual basis. At the same time, there is mounting pressure across the healthcare system to contain costs while improving the quality of cancer care. In response to this pressure, private and government payers are increasingly turning to tools such as alternative payment models (APM) and clinical pathways to improve the efficiency of care, inform coverage decisions, and support shared decision-making. As APMs, clinical pathways and other tools are utilized more broadly, it will be critical that these models support the evidence-based use of innovative biomedical advances, including personalized medicine, and deliver patient-centered, high-value care. Clin Cancer Res; 22(10); 2335-41. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27087022     DOI: 10.1158/1078-0432.CCR-16-0892

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  1 in total

1.  Early Accountable Care Organization Results in End-of-Life Spending Among Cancer Patients.

Authors:  Miranda B Lam; Jie Zheng; E John Orav; Ashish K Jha
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.